Fact-check
Is Dabur Chyawanprash banned in India?
Last checked 10 October 2026
Dabur Chyawanprash is not banned: no ban, recall or failed-test notice naming it is on record, and Dabur India was the plaintiff when the Delhi High Court restrained Patanjali from calling other chyawanprash 'dhoka' on 6 Nov 2025.
- Classification
- Not banned; no regulator action on record
- Tested by
- No regulator action on record
- Reference
- Delhi High Court, Dabur India v Patanjali Ayurved, order of 6 Nov 2025 (Justice Tejas Karia), 2025 SCC OnLine Del 8347
- Latest action
- 6 November 2025
- Last checked
- 10 October 2026
Photo: An Ayurvedic Pharmacy, Rishikesh (1).jpg by Ken Wieland from Philadelphia, USA (CC BY-SA 2.0). All photo credits.
Maharashtra FDA: not of standard quality (NSQ) alerts table
No regulator has acted on this finding. It comes from a published study or a private testing company, and the brand may dispute it.
Scope. A record here does not by itself mean a product or company is unsafe or banned today. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Below: Blacklisted's explanationWe explain what the test or study found. No regulator has acted on it.
Key facts
- Status
- Not banned; no AYUSH regulator action on record
- The court case
- Dabur India v Patanjali Ayurved, Delhi High Court, 6 Nov 2025: Dabur was the plaintiff and won interim relief
- What the court did
- Restrained Patanjali from calling all other chyawanprash 'dhoka'; disparaging a whole class of products is not mere puffery
- Where to look
- Maharashtra FDA's NSQ table of 9 Oct 2026 names other makers and products, not Dabur Chyawanprash
Where the claim comes from
Searches pair Dabur Chyawanprash with 'banned' after the Dabur and Patanjali chyawanprash advertising dispute reached the Delhi High Court in 2025. The dispute was over advertising, and Dabur was the plaintiff.
Dabur Chyawanprash is not banned in India. In the sources we checked there is no ban, recall, failed-test finding or licence action naming it. Maharashtra FDA's table of products that failed state lab tests, as of 9 Oct 2026, lists other makers and other products.
The claim usually traces to a court dispute. On 6 Nov 2025 the Delhi High Court (Justice Tejas Karia), in Dabur India v Patanjali Ayurved, restrained Patanjali from calling all other chyawanprash 'dhoka' (2025 SCC OnLine Del 8347). The court held at the interim stage that disparaging a whole class of products is not mere puffery. Dabur was the plaintiff.
That order concerns a rival's advertising. It is not a finding about the quality or safety of Dabur Chyawanprash.
What this means for you
The 'banned' claim is about a legal dispute
The only court order on record involving Dabur Chyawanprash was won by Dabur. It concerns advertising by a rival, not the quality of Dabur's product.
Questions of safety
No regulator finding on Dabur Chyawanprash is on record in the sources we checked. We do not assess health claims for or against any product.
This is a record of official orders, not medical advice. Do not stop a prescribed medicine without asking your doctor or pharmacist.
Common questions
Is chyawanprash banned in India?
No. We found no ban, recall or lab-test notice on chyawanprash in the sources we checked.
Is Dabur honey banned?
No AYUSH action is on record. Honey is a food and is covered by FSSAI; see the food section.
Official sources and primary records
- Del HC grants interim relief in Dabur v Patanjali chyawanprash caseNewsSCC Online · 12 November 2025
- Maharashtra FDA: not of standard quality (NSQ) alerts tableRegulatorMaharashtra Food and Drug Administration · 9 October 2026
- US FDA import alerts: entries for IndiaRegulatorUS Food and Drug Administration · 9 October 2026